Latest filing published 06 Oct 2020 for Pacgen Life Science Corporation, €2,725.
Alan Clyde Hayes Savage appears in our data through filings on Pacgen Life Science Corporation shares, published by SEDI. The record holds 43 filings, for trades running from 15 October 2015 to 5 October 2020.
Purchases make up the whole of the open-market record (38 purchases, €152k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
In size, the median ticket on the buying side is €543. None of the 38 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The record was last updated on 6 October 2020 with a transaction (€2,725) in Pacgen Life Science Corporation. The latest purchase dates back some time: it was published 2,804 days ago, on 20 February 2019. The median gap between a trade and its publication by SEDI is 1 day. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 43 declarations